When Prozac first appeared, it was a wonder drug--effective, well-tolerated, and safe in overdose. And, said Eli Lilly, only 1.9% of patients in the clinical trials suffered sexual dysfunction as a side effect. Clinicians weren't so sure about that figure.
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Anybody who watched the recent World Series between the Red Sox and the Cardinals got a pretty good education in Viagrology, Levitrology, and Cialisology. Between footage of men shopping at Victoria's Secret and couples soaking in outdoor tubs, it was a challenge to fit in a few double plays and home runs.
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Marlene Dietrich once observed that "in America sex is an obsession, in other parts of the world it is a fact." While that may be true, sex is never terribly easy to discuss, no matter what your longitude and latitude.
Abraham Morgentaler, M.D.
Associate Clinical Professor of Urology,
Harvard Medical School
Author, The Viagra MythDr. Morgentaler has disclosed that he is a member of the speakers bureau of Pfizer, Lilly/ICOS, Solvay, and Auxilium, that he is on the medical advisory boards of Solvay and Auxilium, and that he has a funded fellowship from Auxilium. Dr. Morgentaler has disclosed that testosterone has not been approved by the U.S. Food and Drug Administration for use in the treatment of depression. Please consult product labeling for the approved usage.
Dr. Morgentaler, as a urologist with particular expertise in male sexual dysfunction, what kind of advice might you have for psychiatrists in terms of helping us to differentiate psychogenic from organic sexual problems?
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
If you've seen the new movie “Kinsey,” you already know that the famed sex researcher first made his name writing about the decidedly un-sexy topic of gall wasps. He was fascinated by these creatures because of the marked variability among individuals--a theme that later emerges in his work on human sexuality.
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Rarely have we been exposed to a more bewildering array of data and opinions as over the past year on the subject of antidepressants in children. Ever more definitive meta-analyses and databases are published on a weekly basis. Researcher-clinicians of impeccable credentials look at the same data and deliver opposite opinions.
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Let's face it. With our most troubled, desperate patients, each visit is an exercise in doing something that may very well be impossible: predicting whether they are going to attempt suicide.
Daniel Carlat, MDDr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
Psychiatrists, once relatively immune from malpractice lawsuit, are being sued at an increasing rate. Only about 2% of psychiatrists were sued in 1975; this figure increased to 8% in 1995. And most of these suits are for negligence related to suicides.
Shawn C. Shea, M.D.
Director, Training Institute for Suicide Assessment and Clinical Interviewing
Adjunct Assistant Professor of Psychiatry, Dartmouth Medical School
Dr. Shea has disclosed that he is a member of the speakers bureau of GlaxoSmithKline.
Dr. Shea, in your classic book, The Practical Art of Suicide Assessment (John Wiley & Sons, 2002), you describe the CASE approach to evaluating suicidal ideation. What is the CASE approach?